Today on DrugResearcher.com   'Three way' approach to personalised medicine 3D scaffold elevates drug screening results New US player in contract assay services field R&D news in brief Drugs moving into the clinic: 28

Related Industry News   China in latest drug safety offensive Catalent reshuffles business, reports operating loss SkyePharma posts six-month results Kiddy Tamiflu for the EU

Breaking News on Drug Discovery
Daily  Thursday 20 September 2007		Forward to a colleague

	Product Literature ClonePix FL - explore cell surfaces discover stellar clones ClonePix FL technology makes light-work of selecting and isolating mammalian cell clones by cell surface protein expression, rapidly yielding monoclonal populations for cell based assays, screening, downstream phenotyping/genotyping and basic discovery research... Click Here Access Full Stories 'Three way' approach to personalised medicine UK antibody specialists Oxford Genome Science (OGeS) has signed new deals with Medarex and Biosite in order to help it produce personalised anticancer drugs faster... Read 3D scaffold elevates drug screening results UK researchers have developed a plastic cell scaffold that enables cells to be grown in realistic 3D  structures and promises to enable better cell based drug screening results... Read New US player in contract assay services field The burgeoning US contract assay services arena has witnessed the arrival of a brand new player with the launch of ReachBio, which is opening its business operations this week... Read R&D news in brief DrugResearcher.com brings you a round up of the latest news in pharma research, including a busy week for the US Department of Defence, a terminated RNAi deal, a new type of influenza drug, and more... Read Drugs moving into the clinic: 28 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read
	All News Headlines for: September | August | July
	Product Overview Have you got problems with aching hands in your lab? Lab professionals have twice as much upper limb disorders (URLD) as employees in general. The risk of Repetitive Strain Injury (RSI) increases, when pipetting over 1.5 hours/day. The strain will also have a negative impact on the accuracy and precision. Read more... Click Here
	Related Industry News China in latest drug safety offensive Chinese drug manufacturers could be given a 24-hour deadline by regulators to pull unsafe pharmaceuticals off the market or face a fine, a Chinese newspaper reported... Read Catalent reshuffles business, reports operating loss Catalent Pharma Solutions, the firm born from the spin out of Cardinal Health's contract manufacturing business, is reorganising its production facilities with an expansion of its UK site and the divestiture of... Read SkyePharma posts six-month results SkyePharma is looking towards a positive future despite a pre-tax operating loss of £14.1m (€20.3m), announced in the UK company's unaudited six-month results... Read Kiddy Tamiflu for the EU Roche has just had the child-size, lower strength version of its blockbuster flu treatment Tamiflu (oseltamivir) approved by EU authorities, though possibly just a little too late for this year's flu season... Read Weekly Comment UK gets go-ahead for hybrid embryo research Eight months after the debate started over whether hybrid embryo research should be allowed in the UK, the HFEA has given researchers the thumbs up - but only on a case-by-case basis. Read Product Brochure A revolution in Sales Lead Generation! - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here Previous Headlines Preclinical services news in brief In this week's review of activity within the preclinical research services arena, new deals have emerged involving Alligator Bioscience, Indivumed, and Xceleron... Read Provectus' dye causes tumours to die Provectus has announced positive results for the first human trials of its new anticancer drug, which is based on a compound normally used as a dye... Read Sanofi-Aventis: pipeline update At this week's research and development (R&D) day in Paris, Sanofi-Aventis gave a comprehensive update of its pipeline. DrugResearcher.com was there to bring you the highlights... Read Arcxis accelerates DNA preparation US-based Arcxis Biotechnologies has launched a new device to enable automated nucleic acid preparation from up to eight biological samples in 15 minutes... Read Evotec snaps up preclinical pharma firm, extends into US Evotec has taken its first real foray into the US through the acquisition of a US speciality pharma company, as it continues to move further away from a services business to a fully fledged pharma company... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com